181 related articles for article (PubMed ID: 32207091)
1. Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats.
Nikiforuk A; Litwa E; Krawczyk M; Popik P; Arias H
Pharmacol Rep; 2020 Jun; 72(3):589-599. PubMed ID: 32207091
[TBL] [Abstract][Full Text] [Related]
2. Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain.
Bagdas D; Ergun D; Jackson A; Toma W; Schulte MK; Damaj MI
Eur J Pain; 2018 Jan; 22(1):84-93. PubMed ID: 28809075
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with alpha4beta2 neuronal nicotinic acetylcholine receptor orthosteric ligands.
Weltzin MM; Schulte MK
J Pharmacol Exp Ther; 2010 Sep; 334(3):917-26. PubMed ID: 20516140
[TBL] [Abstract][Full Text] [Related]
4. Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
Liu X
Psychopharmacology (Berl); 2013 Nov; 230(2):203-13. PubMed ID: 23712602
[TBL] [Abstract][Full Text] [Related]
5. Desformylflustrabromine (dFBr), a positive allosteric modulator of the α
DeCristofano L; Decker S; Schulte MK; Suryanarayanan A
Alcohol; 2021 Jun; 93():35-44. PubMed ID: 33652092
[TBL] [Abstract][Full Text] [Related]
6. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
Hamouda AK; Bautista MR; Akinola LS; Alkhlaif Y; Jackson A; Carper M; Toma WB; Garai S; Chen YC; Thakur GA; Fowler CD; Damaj MI
Neuropharmacology; 2021 Jun; 190():108568. PubMed ID: 33878302
[TBL] [Abstract][Full Text] [Related]
8. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats.
Nikiforuk A; Kos T; Potasiewicz A; Popik P
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1300-13. PubMed ID: 26003081
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulator Desformylflustrabromine relieves the inhibition of α2β2 and α4β2 nicotinic acetylcholine receptors by β-amyloid(1-42) peptide.
Pandya A; Yakel JL
J Mol Neurosci; 2011 Sep; 45(1):42-7. PubMed ID: 21424792
[TBL] [Abstract][Full Text] [Related]
10. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
[TBL] [Abstract][Full Text] [Related]
11. Examining the Effects of (α4)3(β2)2 Nicotinic Acetylcholine Receptor-Selective Positive Allosteric Modulator on Acute Thermal Nociception in Rats.
Deba F; Ramos K; Vannoy M; Munoz K; Akinola LS; Damaj MI; Hamouda AK
Molecules; 2020 Jun; 25(12):. PubMed ID: 32630476
[TBL] [Abstract][Full Text] [Related]
12. Reversal of Nicotine Withdrawal Signs Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Male Mice.
Hamouda AK; Jackson A; Bagdas D; Imad Damaj M
Nicotine Tob Res; 2018 Jun; 20(7):903-907. PubMed ID: 29059422
[TBL] [Abstract][Full Text] [Related]
13. Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor.
Hamouda AK; Wang ZJ; Stewart DS; Jain AD; Glennon RA; Cohen JB
Mol Pharmacol; 2015 Jul; 88(1):1-11. PubMed ID: 25870334
[TBL] [Abstract][Full Text] [Related]
14. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
Potasiewicz A; Hołuj M; Kos T; Popik P; Arias HR; Nikiforuk A
Neuropharmacology; 2017 Feb; 113(Pt A):188-197. PubMed ID: 27717880
[TBL] [Abstract][Full Text] [Related]
15. Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor.
Potasiewicz A; Kos T; Ravazzini F; Puia G; Arias HR; Popik P; Nikiforuk A
Br J Pharmacol; 2015 Nov; 172(21):5123-35. PubMed ID: 26276349
[TBL] [Abstract][Full Text] [Related]
16. des-Formylflustrabromine (dFBr): A Structure-Activity Study on Its Ability To Potentiate the Action of Acetylcholine at α4β2 Nicotinic Acetylcholine Receptors.
Dukat M; Jain A; German N; Ferrara-Pontoriero R; Huang Y; Ma Y; Schulte MK; Glennon RA
ACS Chem Neurosci; 2018 Dec; 9(12):2984-2996. PubMed ID: 30028943
[TBL] [Abstract][Full Text] [Related]
17. Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit.
Weltzin MM; Schulte MK
J Pharmacol Exp Ther; 2015 Aug; 354(2):184-94. PubMed ID: 26025967
[TBL] [Abstract][Full Text] [Related]
18. Desformylflustrabromine: A Novel Positive Allosteric Modulator for beta2 Subunit Containing Nicotinic Receptor Sub-Types.
Pandya AA
Curr Pharm Des; 2016; 22(14):2057-63. PubMed ID: 26818864
[TBL] [Abstract][Full Text] [Related]
19. Deconstruction of the α4β2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine.
German N; Kim JS; Jain A; Dukat M; Pandya A; Ma Y; Weltzin M; Schulte MK; Glennon RA
J Med Chem; 2011 Oct; 54(20):7259-67. PubMed ID: 21905680
[TBL] [Abstract][Full Text] [Related]
20. Acute Administration of Desformylflustrabromine Relieves Chemically Induced Pain in CD-1 Mice.
Weggel LA; Pandya AA
Molecules; 2019 Mar; 24(5):. PubMed ID: 30866543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
